During conflicts, humanitarian bodies not only face the obvious security risks of reaching people in need, they also have to deal with the growing bureaucracy involved in getting medicines to them.
The British Society of Rheumatology (BSR) is creating its own evidence database to track the efficacy and long-term safety of new biosimilar products.
A worldwide innovation fund worth up to US$2bn could be set up to encourage the pharmaceutical industry to search for and develop new classes of antibiotics.
Community pharmacists generally support the new medicine service because they think it will benefit patients, according to new research.
Researchers have discovered a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events.
GlaxoSmithKline and Novartis have completed their three-prong multibillion pound business transaction, the companies have announced.
The World Health Organization is appealing for more than US$1bn to meet the health needs of 21 million people in Syria, Iraq, the Central African Republic and South Sudan.
Scientists have identified an important pathway used by the Ebola virus to gain entry into cells that may lead to new therapeutic approaches.
The use of nonsteroidal anti-inflammatory drugs in patients receiving antithrombotic therapy after myocardial infarction doubles the risk of further heart attacks, researchers find.
The US Food and Drug Administration has fast-tracked the approval of the first histone deacetylase inhibitor to treat patients with multiple myeloma.
Pharmacists in India to alert customers to maximum price they can be charged for medicinesSubscription
Medicines regulators in India have put forward proposals to ensure that consumers know the maximum price that they should be charged for certain medicines.
The number of complaints about medicines advertising made to the safety regulator fell by a third in 2014, according to official figures released on 24 February 2015.
Health and social care services in Greater Manchester are preparing to break away from centralised control, following a devolution settlement with the UK government.
A smartphone app that offers up-to-date antibiotic prescribing advice to hospital doctors has won the infection control category in the annual NHS Innovation Challenge Awards.
Children with HIV in developing countries will now have access to generic paediatric formulations of raltegravir following a licence agreement with Merck.
The General Pharmaceutical Council will scrap the ‘satisfactory’ category from community pharmacy premises inspection rankings after concerns that it may be misinterpreted.
Researchers have developed a new nine-component vaccine against human papillomavirus which they believe could increase overall protection against cervical cancers to 90%.
The World Health Organization wants to see universal adoption of syringes that can only be used once, to address the global problem of unsafe injections.
The pharmaceutical industry’s systems for self-regulation of drug advertising and marketing are weak, according to a study published in PLoS Medicine.
The government wants to see a “significant” reduction in inappropriate prescribing of antipsychotic drugs to people with dementia in England in the next five years.
Patients taking long-acting opioids are more than twice as likely to overdose unintentionally than patients taking short-acting opioids, study finds.
Young people seem to contract influenza every other year on average, while adults over 30 seem to contract flu twice a decade, say researchers.
A drug candidate known as “eCD4-Ig” — a fusion of CD4-Ig with a small CCR5-mimetic sulfopeptide — has efficiently neutralised 100% of a diverse panel of HIV-1, HIV-2 and simian immunodeficiency virus isolates.
A study using data from the UK has observed a protective effect of statins against liver cancer, an effect previously seen in countries with high rates of the disease.
A literature review has found that pharmacists operate within a highly-regulated environment that creates the potential for moral distress to occur.
An economic modelling study published in Ophthalmology suggests that wider use of ranibizumab could help prevent sight loss in thousands of US adults with diabetic eye disease.
Five years of creatine at a dose of 10mg/day does not slow disease progression in patients with early, stable Parkinson’s disease, a study published in JAMA shows.
New research suggests that a 10mmHg reduction in systolic BP is associated with significant reductions in death, macrovascular events and microvascular events, with relative risk reductions ranging from 11% to 27%.
Researchers have evaluated the use of eltoprazine, a selective partial agonist at the 5-HT1A and 5-HT1B receptors, for its ability to counteract dyskinesias.